HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Nikos Anastasiou Magdi Yacoub Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Allen, S. Articles by Yacoub, M. Search for Related Content PubMed PubMed Citation Articles by Allen, S. Articles by Yacoub, M.

J Thorac Cardiovasc Surg 1997;113:319-326
© 1997 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

EFFECT OF APROTININ ON VASCULAR REACTIVITY OF CORONARY BYPASS GRAFTS

Received for publication Feb. 23, 1996 revisions requested April 8, 1996; revisions received July 30, 1996 accepted for publication August 23, 1996. Address for reprints: Magdi Yacoub, MD, Department of Cardiothoracic Surgery, Harefield Hospital, Harefield, Middlesex, UB9 6JH, United Kingdom.

Abstract

Objective: Aprotinin reduces postoperative bleeding and the need for transfusion after cardiopulmonary bypass. The current clinical concern about aprotinin is that it may increase the incidence of postoperative graft thrombosis and thromboembolic phenomena. The fact that the mechanism of action of aprotinin is still not completely elucidated and that its effects on the vascular reactivity of bypass conduits are unknown raise doubts regarding its safety. In an attempt to clarify these issues we investigated the vascular reactivity of the human saphenous vein and internal thoracic artery to a range of vasoconstrictor agents in the presence or absence of aprotinin. Methods: Human saphenous vein was obtained from 24 patients and internal thoracic artery from 7 patients undergoing coronary artery bypass. Vessels were set up in organ baths to record changes in vessel wall tension. Results: Endothelium-dependent relaxations to acetylcholine in saphenous vein rings were unaffected after aprotinin treatment. Contractions to the thromboxane analog U46619 were significantly attenuated after aprotinin treatment in the saphenous vein. Maximum responses were reduced from control values of 88 ± 7.5 mN to 49.3 ± 4.8 mN with 1 µmol/L doses of aprotinin (p < 0.05) and 36.6 ± 4.8 mN with 10 µmol/L doses of aprotinin (p < 0.05). There was no attenuation of contractions induced by 5-hyroxytryptamine or noradrenaline after aprotinin incubations. Furthermore, contractions to U46619 in the internal thoracic artery were unaffected by aprotinin. Conclusion: Our data show that there is a preservation of endothelium-dependent responses to acetylcholine and a reduced U46619 vasoconstrictor action on the saphenous vein after aprotinin treatment. Thus the direct effect of aprotinin on the vessel wall could counteract the potential effect of its prothrombotic action on graft patency.

This article has been cited by other articles:

				G. Veres, T. Radovits, H. Schultz, L.-n. Lin, J. Hutter, E. Weigang, Z. Szabolcs, and G. Szabo Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 340 - 345. [Abstract] [Full Text] [PDF]

				J. H. Fischer and M. Steinhoff Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 801 - 804. [Abstract] [Full Text] [PDF]

				T. Shimoyama, N. Tabuchi, K. Kojima, H. Akamatsu, H. Arai, H. Tanaka, and M. Sunamori Aprotinin attenuated ischemia-reperfusion injury in an isolated rat lung model after 18-hours preservation Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 581 - 587. [Abstract] [Full Text] [PDF]

				B. Wei, Y. Liu, Q. Wang, C. Yu, C. Long, Y. Chang, and Y. Ruan Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot Ann. Thorac. Surg., March 1, 2004; 77(3): 918 - 924. [Abstract] [Full Text] [PDF]

				Y. Liu, Q. Wang, X. Zhu, D. Liu, S. Pan, Y. Ruan, and Y. Li Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass Ann. Thorac. Surg., May 1, 2000; 69(5): 1402 - 1407. [Abstract] [Full Text] [PDF]

				D. Royston Hemostatic Drugs in Prothrombotic or Hypercoagulable States Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 376 - 394. [Abstract] [PDF]